Becton, Dickinson and Co. | BDX - Stock

Stock Price
152.14
Daily Change
-2.71 -1.75%
Monthly
-3.87%
Yearly
-25.81%
Q2 Forecast
148.88

Becton, Dickinson and Co. reported $4.08B in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Agilent USD 1.06B 34M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
AngioDynamics USD 65.57M 3.56M Sep/2025
Avanos Medical USD 148M 2.6M Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Bio-Rad Laboratories USD 740.7M 42.5M Dec/2025
Boston Scientific USD 2.94B 22M Dec/2025
Cooper Companies USD 846M 35M Sep/2025
Danaher USD 2.61B 119M Mar/2026
Dentsply International USD 642M 44M Dec/2025
Dexcom USD 629.1M 25M Dec/2025
Edwards Lifesciences USD 1.13B 14.7M Dec/2025
Globus Medical USD 759.28M 12.26M Dec/2025
Insulet USD 452.6M 6.3M Dec/2025
Integra LifeSciences USD 492.73M 3.63M Dec/2025
Intuitive Surgical USD 1.95B 105.1M Mar/2026
J&J USD 14.58B 392M Mar/2026
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.31B 153M Dec/2025
Solventum Corp USD 1.07B 17M Dec/2025
Stryker USD 5.31B 60M Dec/2025
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
Terumo JPY 311.91B 10.92B Sep/2025
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Zimmer Biomet Holdings USD 2.29B 197.3M Dec/2025